BNP Paribas Financial Markets
FOMX

BNP Paribas Financial Markets’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

BNP Paribas Financial Markets’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,588
Closed -$37.2K – 3294
2015
Q4 		$37.2K Sell
4,588
-606
-12% -$4.53K ﹤0.01% 3006
2015
Q3 		$38.1K Buy
5,194
+3,312
+176% +$33.8K ﹤0.01% 3050
2015
Q2 		$19.3K Buy
+1,882
New +$20.8K ﹤0.01% 3072

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BNP Paribas Financial Markets's FOMX Position: Q1 2016 in Review

BNP Paribas Financial Markets sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2016, closing a stake of 4,588 shares — an estimated $37.2K sold.

BNP Paribas Financial Markets first reported a position in FOMX in Q2 2015 and held it in 3 quarters. The position peaked at $38.1K in Q3 2015. 66 funds tracked by Wall St. Rank hold FOMX as of Q1 2016.

  • BNP Paribas Financial Markets reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 4,588 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2016, an estimated $37.2K.
  • BNP Paribas Financial Markets first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $38.1K in Q3 2015.
  • 66 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2016, filed 22 Apr 2016.